Publications | Lund University Publications

1 – 10 of 13

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Glucagon-like+peptide-1%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2024
Mark RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine
Miskelly, Michael G. ^LU ; Lindqvist, Andreas ^LU ; Piccinin, Elena ; Hamilton, Alexander ^LU ; Cowan, Elaine ^LU ; Nergård, Bent Johnny ; Del Giudice, Rita ^LU ; Ngara, Mtakai ^LU ; Cataldo, Luis R. ^LU and Kryvokhyzha, Dmytro ^LU , et al. (2024) In Diabetologia 67(2). p.356-370
- Contribution to journal › Article
2022
Mark Assessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function : Review on Mathematical Modelling Approaches
Pacini, Giovanni ; Ahrén, Bo ^LU ; Göbl, Christian and Tura, Andrea (2022) In Biomedicines 10(5).
- Contribution to journal › Scientific review
2019
Mark Glucagon-like peptide-1 receptor agonists for type 2 diabetes : A rational drug development
Ahrén, Bo ^LU (2019) In Journal of Diabetes Investigation 10(2). p.196-201
- Contribution to journal › Article
2017
Mark Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus : Long-term efficacy with or without rescue therapy
Home, Philip D. ; Ahrén, Bo ^LU ; Reusch, Jane E.B. ; Rendell, Marc ; Weissman, Peter N. ; Cirkel, Deborah T ; Miller, Diane ; Ambery, Philip ; Carr, Molly C. and Nauck, Michael A. (2017) In Diabetes Research and Clinical Practice 131. p.49-60
- Contribution to journal › Article
Mark The vildagliptin experience - 25 years since the initiation of the novartis glucagon-like peptide-1 based therapy programme and 10 years since the first vildagliptin registration
Foley, James E and Ahrén, Bo ^LU (2017) In European Endocrinology 13(2). p.56-61
- Contribution to journal › Article
Mark Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day : An analysis using continuous glucose monitoring
Bergenstal, Richard M. ; Strock, Ellie ; Mazze, Roger ; Powers, Margaret A. ; Monk, Arlene M. ; Richter, Sara ; Souhami, Elisabeth and Ahrén, Bo ^LU (2017) In Diabetes/Metabolism Research and Reviews 33(4).
- Contribution to journal › Article
Mark Albiglutide for the treatment of type 2 diabetes mellitus : An integrated safety analysis of the HARMONY phase 3 trials
Ahrén, Bo ^LU ; Carr, Molly C. ; Murphy, Karen ; Perkins, Christopher ; Rendell, Marc ; Mallory, Jason ; Wilson, Timothy and Johnson, Susan L (2017) In Diabetes Research and Clinical Practice 126. p.230-239
- Contribution to journal › Article
2015
Mark The endocrine heart - metabolic actions of atrial natriuretic peptide
Jujic, Amra ^LU (2015) In Lund University Faculty of Medicine Doctoral Dissertation Series 2015:136.
- Thesis › Doctoral thesis (compilation)
2011
Mark Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
Ahrén, Bo ^LU ; Schweizer, A. ; Dejager, S. ; Villhauer, E. B. ; Dunning, B. E. and Foley, J. E. (2011) In Diabetes, Obesity and Metabolism 13(9). p.775-783
- Contribution to journal › Scientific review
2009
Mark Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice
Pacini, Giovanni ; Ahren, Maria and Ahrén, Bo ^LU (2009) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 296(5). p.1316-1324
- Contribution to journal › Article

« previous
1
2
next »

your query:: Remove keywords: Glucagon-like peptide-1